Latest Articles

It is reported that these failures are due to both the mislabeling of products and contamination from pesticides, bacteria, and processing chemicals.

A member of the United States House of Representatives has submitted a bill to Congress which, if passed, would allow legal cannabis users to become federal employees.

This article explores the current state of play within the area of cancer proteomics, highlights some of the techniques used to investigate the proteome, and looks at the impact of combining proteomics with other ‘omics’ in relation to cancer research.

The study of binding kinetics goes back more than a century and is the foundation of pharmacological theory as we know it today. Yet, although the interactions between drug target, endogenous ligands and exogenous potential drugs are highly complex, the kinetics of most approved and clinically effective drugs are markedly similar.

The accurate identification of bacterial infections is necessary for the fight against antibiotic resistance. This procalcitonin assay is set to aid antibiotic stewardship and improve healthcare outcomes for sepsis patients.

Antimicrobials have revolutionized medicine by enabling treatments for diseases that would once have proven fatal, however,they have since proven to be a double-edged sword.

AC Braddock, CEO of Eden Labs join us to discuss the role of cannabis extraction science and how extraction scientists are creating great cannabis products.

AC Braddock, CEO of Eden Labs joins us to discuss her company's cannabis extraction heritage and, the challenges faced when trying to produce quality, clean cannabis concentrates,

Many recent advances in research have aimed to maximize the amount of data we can produce. But handling all that data is a challenge, and in analytical chemistry, data has more complexity and value than everyday spreadsheets, and tools matching that complexity will be needed to get data back into shape. We discussed how the field should approach these challenges with Andrew Anderson and , Graham McGibbon of Toronto-based analytical software supplier ACD/Labs.

A new device allows researchers to make lithium ion (Li-ion) batteries fail on demand, and that’s a crucial step in making them safer.